| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/10/2002 | CN1358228A Polynucleotide and deduced amino acid sequences from stromal cells |
| 07/10/2002 | CN1358193A Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/10/2002 | CN1358192A 嘌呤衍生物 Purine derivatives |
| 07/10/2002 | CN1358099A Utilization of aminopeptidase inhibitor |
| 07/10/2002 | CN1357541A Phosphatidase A2 inhibitor and its prepn process and use |
| 07/10/2002 | CN1357329A Medicine for treating perennial allergic rhinitis |
| 07/10/2002 | CN1087346C RANTFS peptide and fragments for treatment of inflammation, and compositions with them |
| 07/10/2002 | CN1087176C Vaccine compositions containing 3-O deacylated monophosphoryl lipid A |
| 07/09/2002 | US6417393 Treatment of sickle-cell anemia, brain edema from tumors or ischemia, diarrhea, and glaucoma; hypotensive, wound healing, antiinflammatory and antiallergen agents |
| 07/09/2002 | US6417371 Process for preparing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-acetic acid |
| 07/09/2002 | US6417334 Antagonists to chaperonin 10 |
| 07/09/2002 | US6417227 Methods of delivery of cetyl myristoleate |
| 07/09/2002 | US6417223 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses therof |
| 07/09/2002 | US6417209 Heterocyclic ketone and thioester compounds and uses |
| 07/09/2002 | US6417197 Prodrugs formed with esterification and acidification |
| 07/09/2002 | US6417191 Synergistic combinations of zidovudine, 1592U89 and 3TC |
| 07/09/2002 | US6417188 Arylalkanoylpyridazines |
| 07/09/2002 | US6417185 Heterocyclic enzyme inhibitors |
| 07/09/2002 | US6416991 Genetic engineered protein |
| 07/09/2002 | US6416976 TrpS |
| 07/09/2002 | US6416947 Vaccine adjuvant and vaccine method |
| 07/09/2002 | CA2217455C New substituted derivatives, of biphenyl or phenylpiridine, their preparation process and the pharmaceutical compositions that contain them |
| 07/09/2002 | CA2133218C Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase |
| 07/09/2002 | CA2094137C Novel hydroxamic acid and n-hydroxyurea derivatives and their use |
| 07/09/2002 | CA2024916C Respiratory disorder medicaments comprising salmeterol and fluticasone propionate |
| 07/09/2002 | CA2024872C Medicaments |
| 07/04/2002 | WO2002052268A1 A screening assay for antagonists of human leukocyte receptors |
| 07/04/2002 | WO2002052006A1 Method of examining allergic disease |
| 07/04/2002 | WO2002052002A2 Immunomodulatory polynucleotides and methods of using the same |
| 07/04/2002 | WO2002051988A2 Thymic epithelial progenitor cells and uses thereof |
| 07/04/2002 | WO2002051983A2 Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2002 | WO2002051871A2 Anti-cd28 antibody |
| 07/04/2002 | WO2002051848A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
| 07/04/2002 | WO2002051836A1 Dipeptidyl peptidase iv inhibitor |
| 07/04/2002 | WO2002051835A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 07/04/2002 | WO2002051814A1 Benzoylpyridazines |
| 07/04/2002 | WO2002051807A1 Compounds |
| 07/04/2002 | WO2002051502A1 Combined inhibition of phosphodiesterase-4 (pde-4) and phosphodiesterase-3 (pde-3) as a therapy for th1-mediated autoimmune diseases |
| 07/04/2002 | WO2002051442A1 Concomitant drugs |
| 07/04/2002 | WO2002051438A2 Use of repulsive guidance molecule (rgm) and its modulators |
| 07/04/2002 | WO2002051437A1 Induction of tolerance |
| 07/04/2002 | WO2002051430A2 Methods of modulating toll-related receptor (trr) signaling |
| 07/04/2002 | WO2002051397A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 07/04/2002 | WO2002051254A1 Method of sterilizing antibody-containing milk and products containing sterilized antibody-containing milk |
| 07/04/2002 | WO2002051237A2 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | WO2002051233A2 Universal antimicrobial treatment |
| 07/04/2002 | WO2002033100A3 Regulation of human adenylate cyclase, type iv |
| 07/04/2002 | WO2002033042A3 Recombinant antibody fragments as autoantibody antagonists |
| 07/04/2002 | WO2002030351A3 Improvement of graft acceptance through manipulation of thymic regeneration |
| 07/04/2002 | WO2002030259A3 Disease prevention by reactivation of the thymus |
| 07/04/2002 | WO2002028347A3 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 07/04/2002 | WO2002014317A3 Substituted pyrazoles |
| 07/04/2002 | WO2002012346A8 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 07/04/2002 | WO2002002139A3 Methods and composition for oral vaccination |
| 07/04/2002 | WO2001089557A3 Methods for preventing strokes by inducing tolerance to e-selectin |
| 07/04/2002 | WO2001078779A3 Antibody alpha4beta7 integrin and its use to treat inflammatory bowel disease |
| 07/04/2002 | WO2001078768A3 Targeted vaccine delivery systems |
| 07/04/2002 | WO2001077169A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2001070265A3 Lipopeptide adjuvants |
| 07/04/2002 | WO2001046176A3 Non peptide tachykinin receptor antagonists |
| 07/04/2002 | WO2001036589A9 Human ex vivo immune system |
| 07/04/2002 | WO2001032841A9 Method of in vitro t cell differentiation of cd34+ progenitor cells |
| 07/04/2002 | WO2001032189A9 Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 07/04/2002 | WO2000074687A9 Antisense modulation of b7 protein expression |
| 07/04/2002 | WO2000069897A9 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes |
| 07/04/2002 | WO2000050081A9 Product and method for treatment of conditions associated with receptor-desensitization |
| 07/04/2002 | US20020087205 Transcutaneous photodynamic treatment of targeted cells |
| 07/04/2002 | US20020086996 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates |
| 07/04/2002 | US20020086976 Peptide for use in the treatment of autoimmune disease |
| 07/04/2002 | US20020086972 Adaptor protein FRS2 and related products and methods |
| 07/04/2002 | US20020086906 Drugs, cosmetics or dietary supplements; immunomodulation, antiallergens (IgE mediated allergies, e.g., asthma, rhinitis, eczema); anaphylaxis; autoimmune disorders, e.g., Crohn's disease, antiarthritic and ulcer agents; analgesics |
| 07/04/2002 | US20020086859 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 07/04/2002 | US20020086854 Methods and compositions using norastemizole in combination with leukotriene inhibitors |
| 07/04/2002 | US20020086839 Inhibitors of DNA immunostimulatory sequence activity |
| 07/04/2002 | US20020086834 Flavonoid glycoside of given formula; extract of Cassia alata |
| 07/04/2002 | US20020086832 Immunosuppressing a human after allogenic cell, tissue or organ transplantation by administering a caspase-8 inhibitor |
| 07/04/2002 | US20020086830 (HARC), and polynucleotides which encode it; agonists, antibodies, or antagonists specifically binding HARC, and their use in treating diseases associated with expression of HARC |
| 07/04/2002 | US20020086827 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity |
| 07/04/2002 | US20020086826 Antibodies against ligand for receptor activator of NF-kB |
| 07/04/2002 | US20020086414 Novel ctla4/cd28 ligands and uses therefor |
| 07/04/2002 | US20020086408 Ubiquitin-like conjugating protein |
| 07/04/2002 | US20020086385 Nucleotide sequences coding enzyymatic polypeptide for use in prevention of bacterial infection; bactericides |
| 07/04/2002 | US20020086348 Tolerogenic fragments of natural allergens |
| 07/04/2002 | US20020086297 Gene alteration in the gene for the Gbeta3-subunit of the human G protein |
| 07/04/2002 | US20020086295 Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen |
| 07/04/2002 | US20020086284 Determining sensitivity of a cell to reovirus infection; obtain cells, monitor ras protein signaling, consistent signaling indicates sensitivity to reovirus infection |
| 07/04/2002 | US20020086068 Herbal composition of blend of active components prepared from murrya koenigii and piper betle useful for blocking of 5 lipoxygenase activity leading to the inhibition of leukotriene synthesis, suppression of interleukin-4 production, and enhancement of gamma interferon release |
| 07/04/2002 | US20020086063 Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations |
| 07/04/2002 | US20020086051 For delivering drug directly to interior portions of the body of a mammalian organism, such as to the eye |
| 07/04/2002 | US20020086049 Apoptosis-mimicking synthetic entities and use thereof in medical treatment |
| 07/04/2002 | US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds. |
| 07/04/2002 | US20020086022 A target antigen is mixed with a heterologous antisera specific or cross-reactive to that antigen to produce an inoculant. |
| 07/04/2002 | US20020086018 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3, and TACI |
| 07/04/2002 | US20020086012 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein |
| 07/04/2002 | US20020086011 Administering an effective amount of an OX-2 protein or a nucleic acid encoding an OX-2 protein; use to suppress an immune response and to prevent or treat autoimmune disease, especially arthritis. |
| 07/04/2002 | US20020086005 Tolerizing allografts of pluripotent stem cells |
| 07/04/2002 | US20020086000 Stimulation of thymus for vaccination development |
| 07/04/2002 | US20020085996 Can be administered before, at the same time as, or after the transplant. |
| 07/04/2002 | US20020085992 Method for treating inflammation |
| 07/04/2002 | US20020085615 Differential scanning calorimeter |